Extended Paxlovid courses show mixed results for long COVID symptoms

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.

Optimind Pharma – Private Placement | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – July 3, 2024) – Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) announces a proposed private placement. The Company

July 8, 2024

Doctors See Advantage in AI, but Remain Wary

Most doctors see the advantage of using artificial intelligence (AI) in healthcare, even though they remain concerned about it, an American Medical Association (AMA) survey

December 15, 2023

Macrophages may play a major role in the development of atrial fibrillation

Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.